Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
出版年份 2022 全文链接
标题
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
作者
关键词
-
出版物
ANNALS OF MEDICINE
Volume 54, Issue 1, Pages 1839-1850
出版商
Informa UK Limited
发表日期
2022-07-04
DOI
10.1080/07853890.2022.2095431
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
- (2022) Karen B. Onel et al. ARTHRITIS CARE & RESEARCH
- Efficacy of moderately dosed etoposide in macrophage activation syndrome - hemophagocytic lymphohistiocytosis (MAS-HLH)
- (2021) AnnaCarin Horne et al. JOURNAL OF RHEUMATOLOGY
- Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis
- (2021) Remco Erkens et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Interfering with Interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
- (2021) Emely L Verweyen et al. RHEUMATOLOGY
- IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
- (2021) Howard Lin et al. Blood Advances
- Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
- (2021) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
- (2020) Brigitte Bader-Meunier et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib in refractory adult-onset Still’s disease: 14 cases from a single centre in China
- (2020) Qiongyi Hu et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease
- (2020) Satoshi Sato et al. ANNALS OF THE RHEUMATIC DISEASES
- Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
- (2020) Georgia Griffin et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
- (2020) Franco Locatelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019
- (2020) Scott W. Canna et al. Pediatric Rheumatology
- Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort
- (2019) Mia Glerup et al. ARTHRITIS CARE & RESEARCH
- Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics
- (2019) Priyankar Pal et al. INDIAN JOURNAL OF PEDIATRICS
- IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
- (2019) Shima Yasin et al. RHEUMATOLOGY
- IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome
- (2019) Shima Yasin et al. RHEUMATOLOGY
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
- (2018) Eric S. Weiss et al. BLOOD
- Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab
- (2018) Amélie Leurs et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
- (2018) Victoria L. Arthur et al. Arthritis & Rheumatology
- A comprehensive review on adult onset Still's disease
- (2018) Roberto Giacomelli et al. JOURNAL OF AUTOIMMUNITY
- AA amyloidosis –benefits and prospects of IL-6 inhibitors
- (2018) Yasuaki Okuda Modern Rheumatology
- Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome
- (2017) Noriko Kinjo et al. JOURNAL OF CLINICAL APHERESIS
- Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review
- (2017) Songkiat Chantarogh et al. BMC Nephrology
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications
- (2016) Michael J Ombrello et al. ANNALS OF THE RHEUMATIC DISEASES
- The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013
- (2016) G. Janow et al. JOURNAL OF RHEUMATOLOGY
- Macrophage activation syndrome in the era of biologic therapy
- (2016) Alexei A. Grom et al. Nature Reviews Rheumatology
- Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
- (2015) Shumpei Yokota et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
- (2015) Grant S. Schulert et al. Annual Review of Medicine
- Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
- (2015) V. Boom et al. Pediatric Rheumatology
- Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
- (2015) Nanguneri Nirmala et al. Pediatric Rheumatology
- HLA-DRB1*11and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
- (2015) Michael J. Ombrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
- (2014) Jaime Guzman et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C
- (2014) Sarah Ringold et al. ARTHRITIS CARE & RESEARCH
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Using cyclophosphamide in inflammatory rheumatic diseases
- (2013) Tobias Brummaier et al. European Journal of Internal Medicine
- Thalidomide for systemic onset juvenile idiopathic arthritis
- (2013) K. Sathe et al. INDIAN PEDIATRICS
- Advances from clinical trials in juvenile idiopathic arthritis
- (2013) Daniel J. Lovell et al. Nature Reviews Rheumatology
- Interleukin-18, more than a Th1 cytokine
- (2013) Daniela Novick et al. SEMINARS IN IMMUNOLOGY
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers
- (2012) Christoph Kessel et al. CLINICAL IMMUNOLOGY
- Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
- (2012) Masaki Shimizu et al. CYTOKINE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
- (2011) Timothy Beukelman et al. ARTHRITIS CARE & RESEARCH
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis
- (2010) Claas H Hinze et al. ARTHRITIS RESEARCH & THERAPY
- Tumor Necrosis Factor Inhibitors in the Management of Juvenile Idiopathic Arthritis
- (2010) Susan Shenoi et al. PEDIATRIC DRUGS
- Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis
- (2009) J Narvaez et al. ANNALS OF THE RHEUMATIC DISEASES
- Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis
- (2009) N. M. Wulffraat et al. AUTOIMMUNITY
- Macrophage activation syndrome: Serological markers and treatment with anti-thymocyte globulin
- (2009) Andreea Coca et al. CLINICAL IMMUNOLOGY
- Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states
- (2009) Claudia Macaubas et al. CLINICAL IMMUNOLOGY
- Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000–2007)
- (2009) Mario Abinun et al. MOLECULAR IMMUNOLOGY
- Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report
- (2009) M. Kasher-Meron et al. RHEUMATOLOGY
- Thalidomide: Mechanisms of Action
- (2008) Taraneh Paravar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Amyloidosis—Recent Developments
- (2008) Tom Pettersson et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started